Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

(Reprinted with permission from AmJ Psychiatry 2018; 175:620–630)

Uloženo v:
Podrobná bibliografie
Vydáno v:Focus (Am Psychiatr Publ)
Hlavní autoři: Canuso, Carla M., Singh, Jaskaran B., Fedgchin, Maggie, Alphs, Larry, Lane, Rosanne, Lim, Pilar, Pinter, Christine, Hough, David, Sanacora, Gerard, Manji, Husseini, Drevets, Wayne C.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Psychiatric Association 2019
Témata:
Influential Publications
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996073/
https://ncbi.nlm.nih.gov/pubmed/32015715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.focus.17105
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky